NEXGEL, Inc.
NEXGEL, Inc.
- Market cap
- $550.56K
Your view on NXGLW
Overview
What the company does, where it operates, and who runs it.
About NEXGEL, Inc.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Adam R. Levy
- Headquarters
- 2150 Cabot Boulevard West, Langhorne, PA, US
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Adam R. Levy
- Headquarters
- 2150 Cabot Boulevard West, Langhorne, PA, US
NEXGEL, Inc. is a company that manufactures specialized hydrogels and gels, notable for their high water content, electron beam cross-linking, and aqueous polymer base.
These advanced materials are widely utilized across several sectors, including wound care, medical diagnostics, transdermal drug delivery systems, and various cosmetic applications.
Their diverse product portfolio features items such as facial masks, under-eye patches, blister-shielding foot care, hexagel, cracked heel repair patches, and cooling fever patches. Originally known as AquaMed Technologies, Inc., the company officially adopted the name NEXGEL, Inc. in November 2019.
Founded in 1997, its operations are headquartered in Langhorne, Pennsylvania.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for NEXGEL, Inc.. Starting points for NEXGEL, Inc.: EPS -$13.63, beta 0.77 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for NEXGEL, Inc.. Trailing twelve-month EPS for NEXGEL, Inc. stands at -$13.63. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for NEXGEL, Inc.. NEXGEL, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| SMTISanara MedTech Inc. | Healthcare | NASDAQ | $298.9M | ||
| SOAGYSartorius AG | Healthcare | OTC | $82.3B | ||
| SOLVSolventum Corporation | Healthcare | NYSE | $14.4B | ||
| SRTOYSartorius Stedim Biotech S.A. | Healthcare | OTC | $209.8B | ||
| SSSGYSartorius AG | Healthcare | OTC | $15.8B | ||
| STAASTAAR Surgical Company | Healthcare | NASDAQ | $1.2B | ||
| STSSSharps Technology, Inc. | Healthcare | NASDAQ | $53.7M | ||
| STVNStevanato Group S.p.A. | Healthcare | NYSE | $4.3B | ||
| STXSStereotaxis, Inc. | Healthcare | AMEX | $95.0M | ||
| SUVPFSartorius AG | Healthcare | OTC | $18.7B | ||
| SVSOSheerVision, Inc. | Healthcare | OTC | $2,551 | ||
| TCGGYTecan Group AG | Healthcare | OTC | $2.3B | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold NEXGEL, Inc., and how their positions are changing. At a $550,561 market value, institutional positions materially move NEXGEL, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by NEXGEL, Inc. executives and directors. Shares of NEXGEL, Inc. have traded between $0.01 and $0.31 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for NEXGEL, Inc.. Coverage tracks NEXGEL, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of NEXGEL, Inc.